The Lancet Haematology in conversation with Kim Linton on follicular lymphoma and the EPCORE NHL-1 trial

  • Kim Linton

Press/Media: Research

Period7 Aug 2024

Media contributions

1

Media contributions

  • TitleKim Linton on follicular lymphoma
    Degree of recognitionInternational
    Media name/outletThe Lancet Haematology
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date7/08/24
    DescriptionDr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or refractory follicular lymphoma.

    Read the full article:
    https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00166-2?dgcid=buzzsprout_tlv_podcast_generic_lanhae
    URLhttps://podcasts.apple.com/us/podcast/kim-linton-on-follicular-lymphoma/id1545933550?i=1000664596272
    PersonsKim Linton